Ameriprise’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,100
| Closed | -$2.97K | – | 4005 |
|
|
2023
Q2 | $2.97K | Sell |
14,100
-1,700
| -11% | -$295 | ﹤0.01% | 3901 |
|
|
2023
Q1 | $2.53K | Sell |
15,800
-30,000
| -66% | -$13.3K | ﹤0.01% | 3930 |
|
|
2022
Q4 | $25K | Sell |
45,800
-17,920
| -28% | -$15.2K | ﹤0.01% | 3888 |
|
|
2022
Q3 | $76K | Sell |
63,720
-5,200
| -8% | -$5.61K | ﹤0.01% | 3864 |
|
|
2022
Q2 | $44K | Sell |
68,920
-6,485
| -9% | -$4.98K | ﹤0.01% | 3833 |
|
|
2022
Q1 | $86K | Sell |
75,405
-1,390
| -2% | -$1.66K | ﹤0.01% | 3855 |
|
|
2021
Q4 | $173K | Sell |
76,795
-53,105
| -41% | -$133K | ﹤0.01% | 3809 |
|
|
2021
Q3 | $444K | Buy |
129,900
+30,000
| +30% | +$92.5K | ﹤0.01% | 3443 |
|
|
2021
Q2 | $299K | Buy |
99,900
+7,300
| +8% | +$23.1K | ﹤0.01% | 3642 |
|
|
2021
Q1 | $299K | Buy |
92,600
+76,200
| +465% | +$254K | ﹤0.01% | 3596 |
|
|
2020
Q4 | $35K | Hold |
16,400
| – | – | ﹤0.01% | 3735 |
|
|
2020
Q3 | $19K | Hold |
16,400
| – | – | ﹤0.01% | 3703 |
|
|
2020
Q2 | $15K | Buy |
16,400
+2,300
| +16% | +$2.19K | ﹤0.01% | 3652 |
|
|
2020
Q1 | $12K | Buy |
+14,100
| New | +$16.4K | ﹤0.01% | 3620 |
|
|
2018
Q2 | – | Sell |
-78,220
| Closed | -$164K | – | 3718 |
|
|
2018
Q1 | $164K | Buy |
78,220
+10
| +0% | +$21 | ﹤0.01% | 3515 |
|
|
2017
Q4 | $159K | Sell |
78,210
-800
| -1% | -$1.66K | ﹤0.01% | 3511 |
|
|
2017
Q3 | $105K | Sell |
79,010
-3,710
| -4% | -$4.61K | ﹤0.01% | 3599 |
|
|
2017
Q2 | $130K | Buy |
+82,720
| New | +$160K | ﹤0.01% | 3629 |
|
|
2016
Q3 | – | Sell |
-363,835
| Closed | -$484K | – | 3851 |
|
|
2016
Q2 | $484K | Sell |
363,835
-1,322,791
| -78% | -$6.19M | ﹤0.01% | 3180 |
|
|
2016
Q1 | $8.89M | Buy |
1,686,626
+997,738
| +145% | +$6.11M | 0.01% | 1518 |
|
|
2015
Q4 | $5.41M | Buy |
688,888
+360,464
| +110% | +$3.1M | ﹤0.01% | 1960 |
|
|
2015
Q3 | $2.77M | Buy |
+328,424
| New | +$3.03M | ﹤0.01% | 2426 |
|
|
2014
Q4 | – | Sell |
-221,198
| Closed | -$2.97M | – | 4537 |
|
|
2014
Q3 | $2.97M | Sell |
221,198
-203,804
| -48% | -$2.43M | ﹤0.01% | 2333 |
|
|
2014
Q2 | $5.42M | Sell |
425,002
-352,355
| -45% | -$3.67M | ﹤0.01% | 2030 |
|
|
2014
Q1 | $9.24M | Sell |
777,357
-23,256
| -3% | -$312K | 0.01% | 1584 |
|
|
2013
Q4 | $11.1M | Sell |
800,613
-167,670
| -17% | -$2.37M | 0.01% | 1416 |
|
|
2013
Q3 | $16.9M | Buy |
968,283
+237,031
| +32% | +$4.54M | 0.01% | 1091 |
|
|
2013
Q2 | $11.9M | Buy |
+731,252
| New | +$22.6M | 0.01% | 1317 |
|
Other funds holding INFI
Ameriprise's INFI Position: Q3 2023 in Review
Ameriprise sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 14,100 shares — an estimated $2.97K sold.
Ameriprise first reported a position in INFI in Q2 2013 and held it in 28 quarters. The position peaked at $16.9M in Q3 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Ameriprise reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Ameriprise sold 14,100 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.97K.
- Ameriprise first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
- Ameriprise's Infinity Pharmaceuticals, Inc. position peaked at $16.9M in Q3 2013.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.